Atherosclerosis
Volume 182, Issue 1 , Pages 37-45 , September 2005

Common polymorphisms in the CYP7A1 gene do not contribute to variation in rates of bile acid synthesis and plasma LDL cholesterol concentration

  • Anna Abrahamsson

      Affiliations

    • Department of Medicine, Division of Gastroenterology and Hepatology, Karolinska Institute at Huddinge University Hospital, SE-14186 Stockholm, Sweden
    • These authors made equal contributions to the study.
    • ,
  • Sergey Krapivner

      Affiliations

    • The Atherosclerosis Research Unit, King Gustaf V Research Institute, Department of Medicine, Karolinska Institute at Karolinska Hospital, SE-17176 Stockholm, Sweden
    • These authors made equal contributions to the study.
    • ,
  • Ulf Gustafsson

      Affiliations

    • Department of Surgery, Karolinska Institute at Danderyd Hospital, SE-18288 Danderyd, Sweden
    • ,
  • Olle Muhrbeck

      Affiliations

    • Department of Surgery, Karolinska Institute at Danderyd Hospital, SE-18288 Danderyd, Sweden
    • ,
  • Gösta Eggertsen

      Affiliations

    • Department of Clinical Chemistry, Karolinska Institute at Huddinge University Hospital, SE-14186 Stockholm, Sweden
    • ,
  • Inger Johansson

      Affiliations

    • Department of Environmental Medicine, Division of Molecular Toxicology, Karolinska Institute, SE-17177 Stockholm, Sweden
    • ,
  • Irene Persson

      Affiliations

    • Department of Environmental Medicine, Division of Molecular Toxicology, Karolinska Institute, SE-17177 Stockholm, Sweden
    • ,
  • Bo Angelin

      Affiliations

    • Center for Metabolism and Endocrinology, Karolinska Institute at Huddinge University Hospital, SE-14186 Stockholm, Sweden
    • ,
  • Magnus Ingelman-Sundberg

      Affiliations

    • Department of Environmental Medicine, Division of Molecular Toxicology, Karolinska Institute, SE-17177 Stockholm, Sweden
    • ,
  • Ingemar Björkhem

      Affiliations

    • Department of Clinical Chemistry, Karolinska Institute at Huddinge University Hospital, SE-14186 Stockholm, Sweden
    • ,
  • Curt Einarsson

      Affiliations

    • Department of Medicine, Division of Gastroenterology and Hepatology, Karolinska Institute at Huddinge University Hospital, SE-14186 Stockholm, Sweden
    • ,
  • Ferdinand M. van’t Hooft

      Affiliations

    • The Atherosclerosis Research Unit, King Gustaf V Research Institute, Department of Medicine, Karolinska Institute at Karolinska Hospital, SE-17176 Stockholm, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46 8 51773201; fax: +46 8 311298.

Received 4 November 2004 ,Revised 18 January 2005 ,Accepted 26 January 2005.

References 

  1. Russell DW, Setchell KDR. Bile acid biosynthesis. Biochemistry. 1992;31:4737–4749
  2. Jelinek DF, Andersson S, Slaughter CA, Russell DW. Cloning and regulation of cholesterol 7α-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis. J Biol Chem. 1990;265:8190–8197
  3. Cohen JC. Contribution of cholesterol 7α-hydroxylase to the regulation of lipoprotein metabolism. Curr Opin Lipidol. 1999;10:303–307
  4. Björkhem I, Reihnér E, Angelin B, Ewerth S, Akerlund JE, Einarsson K. On the possible use of the serum level of 7 alpha-hydroxycholesterol as a marker for increased activity of the cholesterol 7 alpha-hydroxylase in humans. J Lipid Res. 1987;28:889–894
  5. Reihnér E, Björkhem I, Angelin B, Ewerth S, Einarsson K. Bile acid synthesis in humans: regulation of hepatic microsomal cholesterol 7 alpha-hydroxylase activity. Gastroenterology. 1989;97:1498–1505
  6. Glueck CJ, Ford S, Scheel D, Steiner P. Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia. JAMA. 1972;222:676–681
  7. Superko HR, Greenland P, Manchester RA, et al. Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia. Am J Cardiol. 1992;70:135–140
  8. Spady DK, Cuthbert JA, Willard MN, Meidell RS. Adenovirus-mediated transfer of a gene encoding cholesterol 7α-hydroxylase into hamsters increases hepatic enzyme activity and reduces plasma total and low density lipoprotein cholesterol. J Clin Invest. 1995;96:700–709
  9. Spady DK, Cuthbert JA, Willard MN, Meidell RS. Overexpression of cholesterol 7α-hydroxylase (CYP7A) in mice lacking the low density lipoprotein (LDL) receptor gene. J Biol Chem. 1997;273:126–132
  10. Wang J, Freeman DJ, Grundy SM, Levine DM, Guerra R, Cohen JC. Linkage between cholesterol 7α-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations. J Clin Invest. 1998;101:1283–1291
  11. Muhrbeck O, Wang FH, Björkhem I, Axelson M, Einarsson . Circulating markers for biosynthesis of cholesterol and bile acids are not depressed in asymptomatic gallstone subjects. J Hepatol. 1997;27:150–155
  12. Axelso M, Björkhem I, Reihnér E, Einarsson K. The plasma level of 7alpha-hydroxy-4-cholesten-3-one reflects the activity of hepatic cholesterol 7 alpha-hydroxylase in man. FEBS Lett. 1991;284:216–218
  13. Sauter G, Berr F, Beuers U, Fischer S, Paumgartner G. Serum concentrations of 7 alpha-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans. Hepatology. 1996;24:123–126
  14. Nilsell K, Angelin B, Liljeqvist L, Einarsson K. Biliary lipid output and bile acid kinetics in cholesterol gallstone disease; evidence for an increased hepatic secretion of cholesterol in Swedish patients. Gastroenterology. 1985;89:287–293
  15. Tornvall P, Båvenholm P, Landou C, de Faire U, Hamsten A. Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction. Circulation. 1993;88:2180–2189
  16. Van den Maagdenberg AMJM, de Knijff P, Stalenhoef AFH , Gevers Leuven JA, Havekes LM, Frants RR. Apolipoprotein E*3-Leiden allele results from a partial gene duplication in exon 4. Biochem Biophys Res Commun. 1989;165:851–857
  17. Thompson JF, Lira ME, Lloyd DB, Hayes LS, Williams S, Elsenboss L. Cholesterol 7α-hydroxylase promoter separated from cyclophilin pseudogene by Alu sequence. Biochim Biophys Acta. 1993;1168:239–242
  18. Wang DP, Chiang JYL. Structure and nucleotide sequences of the human cholesterol 7α-hydroxylase gene (CYP7). Genomics. 1994;20:320–323
  19. Lew DJ, Decker T, Strehlow I, Darnell JE. Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons. Mol Cell Biol. 1991;11:182–191
  20. Alksnis M, Barkhem T, Strömstedt PE, et al. High level expression of functional full length and truncated glucocorticoid receptor in Chinese hamster ovary cells. J Biol Chem. 1991;266:10078–10085
  21. Kalb VF, Bernlohr RW. A new spectrophotometric assay for protein in cell extracts. Anal Biochem. 1977;82:362–371
  22. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem. 1993;268:10739–10745
  23. Cohen JC, Cali JJ, Jelinek DF, et al. Cloning of the human cholesterol 7 alpha-hydroxylase (CYP7) and localization to chromosome 8q11-q12. Genomics. 1992;14:153–161
  24. Cooper AD, Chen J, Botelho-Yetkinler MJ, Cao Y, Taniguchi T, Levy-Wilson B. Characterization of hepatic-specific regulatory elements in the promoter region of the human cholesterol 7α-hydroxylase gene. J Biol Chem. 1997;272:3444–3452
  25. Couture P, Otvos JD, Cupples LA, Wilson PWF , Schaefer EJ, Ordovas JM. Association of the A-204C polymorphism in the cholesterol 7α-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study. J Lipid Res. 1999;40:1883–1889
  26. Shoda J, He B, Tanaka N, et al. Increase of deoxycholate in supersaturated bile of patients with gallstone disease and its correlation with de novo synthesis of cholesterol and bile acids in liver, gallbladder emptying, and small intestine transit. Hepatology. 1995;21:1291–1302
  27. Pullinger CR, Eng C, salen G, et al. Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest. 2003;110:109–117

PII: S0021-9150(05)00107-3

doi: 10.1016/j.atherosclerosis.2005.01.032

Atherosclerosis
Volume 182, Issue 1 , Pages 37-45 , September 2005

Article Tools

* Image Usage & Resolution